SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | 17.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | 17.35% | |||
| Cost of Revenue | -2.75% | 7.65% | |||
| Gross Profit | -2.75% | 24.33% | |||
| SG&A Expenses | -2.75% | 4.43% | |||
| Depreciation & Amortization | -2.75% | 3.81% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | 5.64% | |||
| Operating Income | -2.74% | 137.88% | |||
| Income Before Tax | -2.75% | 126.75% | |||
| Income Tax Expenses | -2.76% | 864.29% | |||
| Earnings from Continuing Operations | 2.82% | 98.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.82% | 98.18% | |||
| EBIT | -2.74% | 137.88% | |||
| EBITDA | -2.75% | 207.96% | |||
| EPS Basic | 0.00% | 98.47% | |||
| Normalized Basic EPS | 0.00% | 118.75% | |||
| EPS Diluted | 0.00% | 98.47% | |||
| Normalized Diluted EPS | 0.00% | 118.75% | |||
| Average Basic Shares Outstanding | 0.00% | 42.66% | |||
| Average Diluted Shares Outstanding | 0.00% | 42.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||